Corebridge Financial »

Celldex Therapeutics shares owned by Corebridge Financial

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Corebridge Financial from 13F filings

Historical chart of Corebridge Financial investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Corebridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Corebridge Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $574k 32k 18.15
2024-12-31 $812k 32k 25.27

More positions owned by Corebridge Financial

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Blackrock Etf Trust Ii Ishares Aaa Clo (CLOA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Nrg Energy Com New (NRG)

View all positions for Corebridge Financial

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics